Investors who lost money with shares in Centene Corporation (NYSE: CNC) should contact the Shareholders Foundation

An investor, who purchased shares of Centene Corporation (NYSE: CNC), filed a lawsuit over alleged violations of Federal Securities Laws by Centene Corporation in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Centene Corporation (NYSE: CNC) have certain options and for certain investors are short and strict deadlines running. Deadline: September 8, 2025. NYSE: CNC investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Saint Louis, MO based Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.

Centene Corporation (NYSE: CNC) reported that its annual Total Revenue rose from over $153 billion in 2023 to over $163.07 billion in 2024, and that its Net Income increased from over $2.7 billion in 2023 to over $3.3 billion in 2024.

On July 1, 2025, Centene Corporation withdrew its 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states, or 72% of Centene's marketplace membership, was lower than expected, according to the complaint. Centene also stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75, the Centene class action lawsuit alleges.

Shares of Centene Corporation (NYSE: CNC) declined from $66.81 per share on February 03, 2025, to as low as $30.59 per share on July 14, 2025.

The plaintiff claims that between December 12, 2024 to June 30, 2025, the Defendants provided investors with material information concerning Centene's expected revenue guidance and adjusted diluted EPS for fiscal year 2025, that the Defendants' statements included, among other things, confidence in the Company's enrollment and morbidity rates, as well as strong retention rates in Centene's Medicare business, that the Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates, and that such statements absent these material facts caused Plaintiff and other shareholders to purchase Centene's securities at artificially inflated prices.

Those who purchased shares of Centene Corporation (NYSE: CNC) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.